Crumly & Associates’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-7,067
Closed -$558K 132
2023
Q4
$558K Buy
7,067
+608
+9% +$43.3K 0.16% 81
2023
Q3
$451K Sell
6,459
-1,093
-14% -$77.4K 0.18% 73
2023
Q2
$522K Buy
7,552
+1,200
+19% +$85.4K 0.21% 67
2023
Q1
$472K Hold
6,352
0.21% 72
2022
Q4
$592K Sell
6,352
-336
-5% -$32.4K 0.22% 53
2022
Q3
$638K Buy
6,688
+79
+1% +$7.82K 0.26% 48
2022
Q2
$612K Sell
6,609
-199
-3% -$19.4K 0.25% 54
2022
Q1
$689K Buy
6,808
+121
+2% +$12.7K 0.26% 61
2021
Q4
$727K Sell
6,687
-521
-7% -$48.1K 0.29% 55
2021
Q3
$612K Sell
7,208
-1,832
-20% -$153K 0.28% 60
2021
Q2
$754K Buy
9,040
+3,470
+62% +$284K 0.37% 45
2021
Q1
$419K Buy
5,570
+954
+21% +$69.5K 0.24% 55
2020
Q4
$342K Buy
4,616
+110
+2% +$7.16K 0.24% 48
2020
Q3
$263K Buy
4,506
+98
+2% +$6.1K 0.22% 43
2020
Q2
$286K Buy
+4,408
New +$278K 0.27% 37
2020
Q1
Sell
-3,817
Closed -$284K 49
2019
Q4
$284K Buy
+3,817
New +$268K 0.29% 40

Other funds holding CVS

Crumly & Associates's CVS Position: Q1 2024 in Review

Crumly & Associates sold out of CVS Health (CVS) in Q1 2024, closing a stake of 7,067 shares — an estimated $558K sold.

Crumly & Associates first reported a position in CVS in Q4 2019 and held it in 16 quarters. The position peaked at $754K in Q2 2021. 2,176 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

  • Crumly & Associates reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
  • Crumly & Associates sold 7,067 CVS Health shares in Q1 2024, an estimated $558K.
  • Crumly & Associates first reported a position in CVS Health in Q4 2019 and held it in 16 quarters.
  • Crumly & Associates's CVS Health position peaked at $754K in Q2 2021.
  • 2,176 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Crumly & Associates's 13F filing for Q1 2024, filed 1 May 2024.